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In this issue of Cell, Hallikas et al. (2006) and Wei et al. (2006) describe different ways 
of identifying direct targets of transcription factors and their corresponding regulatory 
sequences in the genome. Although still under development, these studies provide an 
efficient way to decipher regulatory networks.The identification of downstream tar-
gets of regulatory factors is required 
to understand cellular responses to 
environmental and developmental 
cues. Precise control of gene expres-
sion is achieved through regulators 
such as microRNAs and transcription 
factors (He and Hannon, 2004; Pabo 
and Sauer, 1992). Which genes are 
controlled by gene-specific transcrip-
tion factors is partly determined by the 
DNA binding domain of these proteins. 
This domain allows the transcription 
factor to bind to specific DNA motifs 
in the vicinity of target genes. In the-
ory, the availability of whole genome 
sequences should have made the job 
of finding transcription factor targets 
straightforward, for example, by allow-
ing the location of recognition motifs 
to be simply looked up in the genome 
sequence. In practice, the task of 
determining transcription factor targets 
is still daunting, especially for organ-
isms with complex genomes. Two 
papers in this issue of Cell (Hallikas et al., 2006; Wei et al., 2006) describe 
different ways of locating direct targets 
of transcription factors and their cor-
responding regulatory regions. The 
studies focus on transcription factors 
that are important for development 
and oncogenesis. The results under-
score the importance of such work 
and indicate that there is still much to 
be discovered about even well-char-
acterized transcription factors. Addi-
tionally, these results emphasize that 
combinations of different approaches 
will be required for the complete deter-
mination of regulatory networks.
Prior to the availability of whole 
genome sequences, methods for 
determining transcription factor targets 
were cumbersome. Such studies usu-
ally began by studying easily accessi-
ble proximal promoter sequences of a 
candidate target gene. Important reg-
ulatory DNA motifs were determined 
by mutating promoter sequences (pro-
moter-bashing). This was followed by 
arduous hit-or-miss approaches such Cell 124, as electrophoretic mobility shift assays, 
biochemical purification, or expression 
cloning to identify the corresponding 
transcription factors. The availabil-
ity of whole genome sequences has 
reversed this process and has made 
it possible to develop more exhaustive 
search methods.
The first contribution of whole 
genome sequences for finding tran-
scription factor targets has been the 
development of microarray technol-
ogy to measure mRNA expression 
(Young, 2000). This can identify all 
genes that exhibit significant changes 
in mRNA levels upon inactivation of 
a transcription factor. The degree 
to which all direct targets are found 
depends on functional redundancy 
and whether the particular devel-
opmental stage or growth condition 
being studied completely covers the 
role of the transcription factor. The 
portion of such genes that actually 
represents direct targets is dependent 
on the number and the nature of indi-January 13, 2006 ©2006 Elsevier Inc. 21
rect effects. For the purpose of find-
ing direct transcription factor targets, 
microarray expression profiling on its 
own is insufficient. However, because 
the readout of microarray expression-
profiling experiments (mRNA levels) is 
close to the process of interest (tran-
scription), it is the best way of char-
acterizing the amazing spectrum of 
regulatory changes that occur during 
diverse cellular programs.
A more direct way in which the avail-
ability of whole genome sequences can 
in principle contribute to finding tran-
scription factor targets is by search-
ing for the corresponding recognition 
motif within the genome sequence 
itself. This approach is taken by Hal-
likas et al. (2006). Previous endeavors 
have made it clear that two major hur-
dles need to be overcome, especially 
for complex genomes. First, the rec-
ognition motif needs to be well defined 
as knowledge of a single binding site 
is not sufficient. DNA sequence motifs 
generally have a “loose” consensus 
that can only be determined by com-
parison of a large collection of binding 
sites. One significant aspect of the cur-
rent study is the initial determination of 
the DNA binding specificities of the 
transcription factors in order to yield a 
consensus binding site for searching 
the genome.
The second major hurdle is the 
search space itself. Mammalian 
genomes are enormous compared to 
the six to eight base-pair DNA motifs 
generally recognized by transcription 
factors. Also, because consensus 
binding motifs are loose, the number 
of putative binding sites vastly exceeds 
the number of functional sites. One 
way of reducing the search space is 
to restrict the analysis to promoters, 
relatively short regions of regulatory 
DNA immediately upstream of gene 
coding regions. This has several dis-
advantages. It relies on accurate 
genome annotation, which has not 
been achieved yet for all genes or non-
coding RNAs in most genomes. Fur-
thermore, it excludes finding binding 
sites in enhancer regions that can be 
located many tens of kilobases away 
from the transcribed DNA under its 
control (Hertel et al., 1997). Hallikas 
et al. (2006) have circumvented such 22 Cell 124, January 13, 2006 ©2006 Elsedisadvantages by making use of two 
additional properties of regulatory 
DNA sequences: its conserved nature 
and the fact that on such regulatory 
regions the binding sites of many dif-
ferent transcription factors tend to 
cluster together. The authors compare 
orthologous regulatory sequences 
based on aligning transcription factor 
binding sites rather than the sequence 
itself and have also introduced a pen-
alty score for sequences inserted 
between binding sites that may com-
promise cooperative binding. All of 
these features have been combined 
into a scoring scheme algorithm called 
EEL (enhancer element locator), which 
is capable of identifying conserved 
enhancer elements. Another impor-
tant feature of this study is the experi-
mental validation of enhancer activity 
for several of their in silico predictions.
A more direct approach for iden-
tification of targets is to determine 
transcription factor location on DNA 
in vivo by chromatin immunoprecipita-
tion (ChIP) (Orlando et al., 1997). This 
technique uses antibodies against 
specific transcription factors to isolate 
the bound DNA sequences embed-
ded in chromatin. ChIP can be cou-
pled to microarray technology (Ren 
et al., 2000). Although representa-
tion of entire genomes is feasible, a 
large number of arrays are currently 
required to completely cover the larg-
est genomes properly. The approach 
taken by Wei et al. (2006) circumvents 
this problem by coupling ChIP with 
paired-end ditag sequencing (ChIP-
PET). This method extracts two 18 bp 
sequence tags, one from each end of 
a DNA fragment isolated by ChIP, and 
joins these two sequences together. 
These concatenated tags are then 
sequenced to identify transcription 
factor binding sites. The relatively unbi-
ased nature of this approach makes it 
more favorable than single array stud-
ies with incomplete genome cover-
age. In the long run it is likely that the 
ChIP-PET technique will be replaced 
by arrays with a higher number of fea-
tures than is currently feasible.
So what do these new technolo-
gies deliver? The EEL tool (Hallikas 
et al., 2006) correctly predicts several 
well-known enhancers in Drosophila vier Inc.and mammals. In a selected set of 
13 known Wnt/Tcf4 targets, a sig-
nificant enrichment of Tcf4 cognate 
sequences was seen in the predicted 
enhancer elements near these genes. 
A genome-wide search for Tcf4-driven 
enhancer elements identified 132 can-
didates. A total of six mapped close to 
previously reported Tcf target genes, 
which seems a low number given 
the hundreds of published Tcf tar-
get genes (for example, http://www. 
stanford.edu /~rnusse /pathways /
targets.html). Expression analysis 
revealed that out of 12 genes ana-
lyzed, 5 were expressed in at least one 
embryonic site where Wnt regulation 
is known to occur. Two Tcf4-driven 
enhancers were predicted near the 
Wnt target gene c-myc. Both enhanc-
ers were shown to control tissue-spe-
cific transcription of reporter genes 
in transgenic mice, but regulation by 
Wnt/Tcf4 was not investigated.
A genome-wide search for enhancer 
elements containing binding sites for 
the Hedgehog transcription factor 
GLI identified 42 candidates including 
two out of the three in vivo validated 
Hedgehog targets. For 16 other pre-
dicted GLI-controlled enhancers, the 
expression of the associated genes 
was determined. For five of these 
genes, the expression patterns were 
consistent with regulation by Hedge-
hog. Three out of four predicted that 
GLI-driven enhancers exerted control 
over the expression of reporter genes 
in transgenic mice. Additionally, two 
out of four potential GLI-controlled 
enhancers in the N-myc gene acted as 
transgenic enhancers in vivo, although 
whether Hedgehog/GLI signaling was 
involved was not addressed. Taken 
together, EEL appears to be a power-
ful tool to identify enhancer regions. 
However, its strength to make more 
specific predictions, such as control 
by Hedgehog or Wnt, awaits further 
experimental confirmation.
Ruan and colleagues applied their 
ChIP-PET method to identify p53 tar-
gets in a colorectal cancer cell line in 
which p53 is activated. In total, 1776 
potential p53 targets were found 
more than once in the over 0.5 million 
sequenced ditags. When these p53 
target genes were compared with a 
list of 66 previously proposed p53 tar-
get genes, 41 were found on both lists. 
Further ChIP analysis indicated that 
only three of the “missed” genes in this 
set of 66 actually contain p53 binding 
sites, implying that the ditag approach 
produced few false negatives. Moreo-
ver, when 40 sequences were ran-
domly selected from a higher confi-
dence ditag list, all could be confirmed 
by conventional ChIP. The study had 
predictive value; from the collection 
of targets, the consensus p53 bind-
ing site could be refined and almost 
one hundred new p53 targets are pro-
posed. Previously, a ChIP array-based 
study had assigned p53 binding sites 
to chromosomes 21 and 22, using the 
same cell line, albeit under different 
experimental conditions (Cawley et al., 
2004). It is somewhat disconcerting to 
note that there is little overlap between 
the sets of proposed p53 binding sites 
from these two studies.
Besides the importance for under-
standing individual transcription fac-
tors, such genome-wide approaches 
are pivotal for deciphering regulatory Sensory experiences alter the elec-
trical properties of ensembles of 
neurons. Retention of this altered 
state of neuronal activity is thought 
to constitute memory. Work on both 
vertebrates and invertebrates sug-
gests that this alteration of neuronal 
properties is partly due to the change 
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Local protein synthesis in the sy
in learning and memory. Howev
synthesis has been lacking. In 
protein synthesis in the antenn
learning.  This protein synthesisnetworks, one of the principal goals  of 
what is currently called systems biology. 
The two types of approaches are com-
plementary. ChIP-based approaches 
are more direct but are limited by the 
particular developmental stage or 
growth condition analyzed. Bioinfor-
matic predictions are perhaps better 
able to identify all possible regulatory 
regions, but these then need more rig-
orous testing for activity and transcrip-
tion factor binding. The EEL approach 
relies in part on orthologous regulatory 
regions and assumes that binding site 
specificities will also be conserved. The 
degree of both assumptions has not yet 
been clearly established. Only a subset 
of transcription factor binding sites are 
presently included in the EEL analysis. 
Expansion will therefore require deter-
mination of more consensus binding 
sites. This may be better driven by 
the results of ChIP studies than by in 
vitro selection of binding sites. Both 
methods, as well as array-based ChIP, 
require further development. However, 
in comparison to old-fashioned “pro-
moter-bashing,” these studies provide Cell 124, 
in the molecular composition of the 
synapse activated by a particular 
pattern of activity. Proteins can be 
made locally in the synapse in addi-
tion to the cell body, and this local 
synthesis can lead to synapse-spe-
cific changes in molecular composi-
tion (Steward and Schuman, 2001).
ries
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napse is required for synaptic plas
er, direct evidence that behaviora
this issue of Cell, Ashraf et al. (2
al lobe synapses of the fruit fly 
 is regulated by the RNA-induceefficient tools for deciphering regulatory 
networks in the postgenomic era.
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Previous studies suggested that 
local protein synthesis in the synapse 
has at least two distinct functions: 
synthesis of retrograde messengers 
that travel from the synapse to the 
cell body to activate mRNA synthesis 
and “marking” of the activated syn-
apse to selectively use the proteins 
ticity and has been implicated 
l training induces local protein 
006) observe persistent local 
following olfactory-avoidance 
d silencing complex (RISC). 
